Precision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and ...
PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics (Nasdaq: AIPT) (The “Company”) is a company applying artificial intelligence to personalized medicine and drug discovery. Their CEO, Dr. Carl Schwartz, and Richard Gabriel, a consultant …